(Q37594763)

21 August 2017

1 reference

title

Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis (English)

1 reference

21 August 2017

Jon Brendan Wiggins

1

1 reference

21 August 2017

Ramona Rajapakse

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Expert Opinion on Drug Metabolism & Toxicology

21 August 2017

published in

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

1279-1284

1 reference

Incidence and prevalence of ulcerative colitis in Punjab, North India

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Benign and malignant colorectal strictures in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Modulation of human colonic arachidonic acid metabolism by sulfasalazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Mesalazine-associated interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Acute interstitial nephritis due to mesalazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Balsalazide-induced myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Possible mesalamine-induced pericarditis: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

Identification and isolation of a membrane protein necessary for leukotriene production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903206996

10.1517/17425250903206996

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference